Eurofins Genomics
Eurofins Genomics, a leading player in the genomics industry, is headquartered in Germany (DE) and operates across major regions in Europe, North America, and Asia. Founded in 1997, the company has established itself as a trusted provider of high-quality genomic services, including DNA sequencing, gene synthesis, and oligonucleotide production. With a commitment to innovation, Eurofins Genomics offers unique solutions tailored to the needs of researchers and businesses in biotechnology, pharmaceuticals, and academic institutions. The company’s state-of-the-art technology and rigorous quality control processes have positioned it as a market leader, recognised for its rapid turnaround times and exceptional customer service. Eurofins Genomics continues to achieve significant milestones, reinforcing its reputation as a go-to partner for genomic research and development.
DitchCarbon Score
How does Eurofins Genomics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eurofins Genomics's score of 20 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eurofins Genomics's reported carbon emissions
Eurofins Genomics, headquartered in Germany (DE), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that Eurofins Genomics is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. This lack of information suggests that while the company may be aware of the importance of sustainability, further transparency regarding their carbon emissions and reduction strategies is needed to fully assess their environmental impact. As the industry increasingly prioritises climate commitments, Eurofins Genomics will likely need to establish clear targets and report on their progress to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eurofins Genomics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
